| Literature DB >> 24155922 |
Jingjing Li1, YaQi Pan, QiuJu Deng, Hong Cai, Yang Ke.
Abstract
Eleven novel human papillomavirus (HPV) types were isolated and characterized from healthy individuals in China. HPV163 belongs to the γ-1 species, HPV 164 and HPV 168 fit in the γ-8 species, HPV 165 and KC5 belongs to the γ-12 species, HPV 168 is closely allied with the γ-4 species, HPV 169 is closely related to the γ-11 species, and HPV 170 is related to the γ-12 species. In addition, HPV 161, HPV 162, and HPV 166 may form a new HPV species of the γ-PV genus. The prevalence of these HPV types in the normal population is low.Entities:
Mesh:
Year: 2013 PMID: 24155922 PMCID: PMC3796542 DOI: 10.1371/journal.pone.0077116
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Systematic positions of novel HPVs.
Eleven novel HPVs (HPV 161-170, KC5) were nested within the Gammapapillomavirus Genus. The evolutionary history was inferred by using the Bayesian and ML methods. A Bayesian consensus tree was based on the whole length of the L1 ORFs. Numbers on branches are bootstrap support values to the clusters to their right (upper number: ML criterion, values, 50 are not shown) and Bayesian posterior probabilities (lower number, values, 0.90 are not shown). The tree is rooted with selected Mu and Nu species. The analysis involved 68 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 1263 positions in the final dataset. Bar, 0.2 nucleotide substitutions per site.
*: Particular types show incongruent systematic positions as inferred from E1-E2 gene phylogenies (Supplementary file).
Genome lengths, nucleotide positions on the genome and sizes of individual ORFs and URRs.
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Genome | E6 | E7 | E1 | E2 | E4 | L2 | L1 | #URR | |
| HPV 161 | 7237 | 199-621 (141) | 618-911 (98) | 895-2709 (605) | 2642-3820(393) | 3237-3578 (342)* | 3820-5361 (514) | 5373-6896 (508) | 539 |
| HPV 162 | 7212 | 127-546 (140) | 546-851 (102) | 835-2658 (608) | 2591-3760 (390) | *3096-3518 (141) | 3757-5277 (507) | 5288-6808 (507) | 530 |
| HPV 163 | 7231 | 177-605 (143) | 602-901 (100) | 888-2711 (608) | 2647-3867 (407) | *3236-3628 (131) | 3870-5420 (517) | 5435-6958 (508) | 449 |
| HPV 164 | 7231 | 89-508 (140) | 505-798 (98) | 782-2584 (601) | 2514-3701 (396) | 2986-3477 (164) | 3703-5277 (525) | 5289-6866 (526) | 453 |
| HPV 165 | 7128 | 96-515 (140) | 512-793 (94) | 777-2603 (609) | 2536-3726 (397) | *3110-3481 (124) | 3801-5243 (481) | 5256-6776 (507) | 447 |
| HPV 166 | 7212 | †327-716 (140) | 718-1023 (102) | 1007-2830 (608) | 2763-3932 (390) | *3358-3690 (111) | 3932-5464 (511) | 5475-6995(507) | 516 |
| HPV 167 | 7228 | 96-515 (140) | 512-805 (98) | 789-2603 (605) | 2536-3741 (402) | *3128-3499 (124) | 3750-5258 (503) | 5269-6819 (517) | 504 |
| HPV 168 | 7204 | 381-800 (140) | 797-1090 (98) | 1074-2876 (601) | 2806-3984 (393) | 3278-3760 (161) | 3986-5548 (521) | 5560-71313 (524) | 453 |
| HPV 169 | 7251 | 157-588 (144) | 591-890 (100) | 874-2685 (604) | 2621-3793 (391) | 3048-3566 (173) | 3795-5285 (497) | 5294-6871 (526) | 536 |
| HPV 170 | 7415 | 316-753 (146) | 729-1013 (95) | 1003-2856 (618) | 2798-4012 (405) | *3363-3770 (136) | 4014-5582 (523) | 5593-7149 (519) | 581 |
| KC5 | 7143 | 80-502 (141) | 492-773 (94) | 757-2559 (601) | 2477-3664 (396) | 3075-3434 (120) | 3666-5201 (512) | 5212-6732 (507) | 489 |
# Upstream regulatory region; * Putative E4 ORF without an ATG; † E6 uses the second ATG.
L1 nucleotide sequence similarities between novel HPV types and known HPVs by the Blast program (Ling et al., 2013).
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| HPV 161 | JX413109 | *HPV 162 | 78% | HPV 135 (γ-15) | 67% |
| HPV 162 | JX413108 | *HPV 166 | 82% | HPV 135 (γ-15) | 67% |
| HPV 163 | JX413107 | HPV 170 | 68% | *HPV 95 (γ-1) | 73% |
| HPV 164 | JX413106 | KC5 | 67% | *HPV 112 (γ-8) | 78% |
| HPV 165 | JX444072 |
| 70% | *HPV 148 (γ-12) | 70% |
| HPV 166 | JX413104 | *HPV 162 | 82% | HPV 130 (γ-10) | 66% |
| HPV 167 | KC862317 | HPV 170 | 66% | *HPV 60 (γ-4) | 67% |
| HPV 168 | KC862318 | *HPV 164 | 76% | *HPV 112 (γ-8) | 76% |
| HPV 169 | JX413105 | KC5 | 65% | *HPV 126 (γ-11) | 74% |
| HPV 170 | JX413110 | HPV 163 | 68% | *HPV 123 (γ-7) | 76% |
| KC5 | JX444073 | HPV 165 | 70% | *HPV 148 (γ-12) | 72% |
* Most closely related HPV types
Figure 2Strategy of amplification of the intact novel HPV genome.
(A) Reverse PCR primers were design according to the known FA fragment nested in the L1 ORF to amplify the almost intact HPV genome, but lack of a small part of the genome; (B) Reverse PCR primers were designed according to the sequence obtained from (A), and primers were located inside the LCR region.
Characteristics of novel HPV positive samples and co-infection information.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| HPV 161 | 7 | M | 50 | HPV 5, KC94 | HPV 167 | 8 | F | 53 | - |
| M | 42 | HPV 21 | F | 35 | FA48 | ||||
| F | 29 | - | M | 31 | - | ||||
| F | 41 | FA12.2, HPV 3 | M | 54 | FA57, HPV 10, KC139 | ||||
| F | 36 | M | 47 | HPV 16 | |||||
| M | 32 | HPV 75 | F | 53 | HPV 3 | ||||
| M | 49 | HPV 5, KC73 | F | 31 | FA105, HPV 11,HPV 47 | ||||
| HPV 162 | 5 | F | 45 | - | M | 38 | - | ||
| M | 58 | - | HPV 168 | 2 | M | 45 | HPV 3 | ||
| M | 61 | HPV 3 | M | 46 | FA54, HPV 3 | ||||
| M | 32 | - | HPV 169 | 1 | F | 51 | HPV 94 | ||
| F | 45 | HPV 3 | HPV 170 | 9 | M | 45 | - | ||
| HPV 163 | 2 | F | 34 | - | F | 56 | - | ||
| HPV 92 | F | 37 | KC 34 | ||||||
| HPV 164 | 4 | M | 34 | HPV 12, HPV 3 | M | 32 | - | ||
| M | 45 | - | M | 56 | HPV 3 | ||||
| F | 32 | - | F | 63 | - | ||||
| M | 37 | HPV 57 | M | 54 | HPV 3 | ||||
| HPV 165 | 2 | F | 27 | - | F | 66 | - | ||
| F | 38 | - | F | 53 | - | ||||
| HPV 166 | 8 | F | 41 | HPV 22 | KC5 | 1 | F | 44 | HPV 22, HPV 94, KC 5 |
| M | 54 | HPV 27, HPV 49 | |||||||
| M | 48 | - | |||||||
| M | 35 | - | |||||||
| M | 62 | HPV 47 | |||||||
| F | 43 | - | |||||||
| M | 57 | - | |||||||
| F | 43 | HPV 3 |
* “M”: Male; “F”: Female; “- ”: No other HPV infection